Evidence map›Paper›PMID 28003731›Full record

ArticleMolecular vision2016

A regulatory sequence from the

Maria K E Blixt, Finn Hallböök

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Heterogeneity in retinoblastoma: a tale of molecules and models.Clinical and translational medicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maria K E BlixtDepartment of Neuroscience, Faculty of Medicine, Uppsala University, Uppsala, Sweden.
Finn HallböökDepartment of Neuroscience, Faculty of Medicine, Uppsala University, Uppsala, Sweden.
Uppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCombining techniques of episomal vector gene-specific Cre expression and genomic integration using the piggyBac transposon system enables studies of gene expression-specific cell lineage tracing in the chicken retina. In this work, we aimed to target the retinal horizontal cell progenitors.

methodsA 208 bp gene regulatory sequence from the chicken

resultsCells that drove Cre expression from the regulatory RXRγ208 sequence excised the floxed STOP-sequence and expressed GFP. The approach generated a stable lineage with robust expression of GFP in retinal cells that have activated transcription from the RXRγ208 sequence. Furthermore, GFP was expressed in cells that express horizontal or photoreceptor markers when electroporation was performed between developmental stages 22 and 28. Electroporation of a stage 12 optic cup gave multiple cell types in accordance with

conclusionsIn this study, we describe an easy, cost-effective, and time-efficient method for testing regulatory sequences in general. More specifically, our results open up the possibility for further studies of the

Indexed as

AnimalsCell LineageChick EmbryoChickensElectroporationGene Expression Regulation, DevelopmentalGenetic VectorsGreen Fluorescent ProteinsIntegrasesOtx Transcription FactorsPAX6 Transcription FactorPhotoreceptor Cells, VertebratePolymerase Chain ReactionRegulatory Elements, TranscriptionalRegulatory Sequences, Nucleic AcidRetinaCre recombinaseenhanced green fluorescent proteinGreen Fluorescent ProteinsIntegrasesOtx Transcription FactorsPAX6 Transcription FactorRetinoid X Receptor gamma

Identifiers

PMID28003731
PMCPMC5166796
OpenAlexW2565140378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.